The invention concerns isolated peptides, compositions and methods of use for treating tumors infiltrated with macrophages, such as glioblastomas.

GLIA Sp. z o.o. was the leader of patent protection and commercialization related activities until the change of the business strategy of the company, currently the intellectuall property is back to the Institute.

For more information contact Technology Transfer Office.